The rise within the prescription of ADHD medication is robust and Sweden stands out internationally. It was in opposition to this background that Social Affairs Minister Jakob Forssmed (KD) introduced a brand new mission to the Medical Merchandise Company to extend data of the neuropsychiatric situation.
– Sweden excels. The variety of diagnoses will increase sharply over time, and Sweden is challenged by the truth that there are not any indicators that the event is slowing down, mentioned Jakob Forssmed at right this moment’s press convention.
An essential a part of the task will likely be to analyze the results of an prolonged proper of prescription.
– In the present day there’s a requirement that prescribing and renewing prescriptions should happen inside specialised psychiatry, inside BUP and grownup psychiatry, however with a pointy enhance in analysis, this creates huge strain on the companies and lengthy queues for sufferers, mentioned the Minister of Social Affairs and continued:
– We have to assessment whether or not we will do that extra effectively.
Extra exactly, it’s about reviewing the results of a attainable prolonged prescription proper for ADHD medication. The query is what it will imply that apart from docs in psychiatry could be allowed to put in writing and renew prescriptions.
– It’s about each decreasing the executive burden, however above all about youngsters and younger folks getting the correct care on the proper time and on the proper stage, mentioned the Minister of Social Affairs.
Jakob Forssmed emphasised that Sweden stands out as a result of the worldwide prevalence of ADHD is 5 to 7 p.c amongst youngsters, and three p.c amongst adults. Sweden is greater. The Nationwide Board of Well being and Welfare estimates that 10.5 p.c of boys and 6 p.c of women in Sweden had an ADHD analysis in 2022.
The state of affairs is difficult because the Nationwide Board of Well being and Welfare expects the prevalence to stage off solely when the proportion of boys with ADHD is 15 per cent and the proportion of women with the analysis is 11 per cent.
The Swedish Medicines Company investigators should, amongst different issues, additionally:
- examine the massive variations in prescribing of ADHD medication between completely different areas.
- perform medical data critiques that can »create situations for validation of the ADHD analysis«.
- develop forecasting and evaluation instruments.
- assessment present therapy suggestions.
Concerning the final level, the minister talked about that the newest suggestions concerning ADHD drug therapy for youngsters and younger folks got here in 2016.
– Quite a bit has occurred since then. It’s merely an explosion of diagnoses, and there have been new medication, new analysis and new indicators. That warrants a assessment, he mentioned, including that drug remedy is certainly one of a number of attainable remedies.
The Minister of Social Affairs additionally introduced up a few theories about why the proportion with analysis and drug therapy has elevated a lot. It might be that consciousness of the analysis has elevated, that the diagnostic standards have been broadened and that extra individuals are receiving a neuropsychiatric analysis as an alternative of one other analysis. There’s additionally a notion that analysis is a proper or casual requirement to obtain assist in school, he mentioned.
Jakob Forssmed concluded the press convention by emphasizing the necessity for extra data.
– We’d like higher data about why Sweden stands out, about why it differs between the areas, how we will higher assist youngsters, younger folks and adults with ADHD and methods to create the correct situations for the correct drug therapy and different remedies, mentioned the Minister of Social Affairs.
The Nationwide Board of Well being and Welfare: Elevated withdrawals and prices
- The affected person inhabitants handled with medication is rising and the speed of enhance is and has been excessive, particularly since 2019.
- The proportion of kids and younger individuals who obtained an ADHD analysis has elevated by upwards of fifty p.c between 2019 and 2023.
- Amongst youngsters, roughly 75 p.c are handled with medication after a analysis.
- Between 2022 and 2023, the variety of sufferers who’ve taken at the very least one ADHD drug has elevated from roughly 189,000 folks to roughly 218,000 folks, akin to a rise price of 15 p.c.
- The price of ADHD medication amounted to SEK 1.3 billion in 2023 and is estimated to proceed rising to SEK 1.5 billion in 2024.
Supply: »Pharmaceutical gross sales in Sweden – evaluation and forecast 2024–2027« (Report from the Nationwide Board of Well being and Welfare).
Lakartidningen.se 2024-05-24
